Inherited Breast Cancer in Nigerian Women
Authors:
- Yonglan ZhengYZYonglan Zheng
- Tom WalshTWTom Walsh
- Suleyman GulsunerSGSuleyman Gulsuner
- Silvia CasadeiSCSilvia Casadei
- Ming K. LeeMLMing K. Lee
- Temidayo O. OgundiranTOTemidayo O. Ogundiran
- Adeyinka AdemolaAAAdeyinka Ademola
- Adeyinka G. FalusiAFAdeyinka G. Falusi
- Clement A. AdebamowoCAClement A. Adebamowo
- Abideen O. OluwasolaAOAbideen O. Oluwasola
- Adewumi AdeoyeAAAdewumi Adeoye
- Abayomi OdetundeAOAbayomi Odetunde
Open Access
- 1 October 2018
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 36 (28) , 2820-2825
Abstract
Purpose: Among Nigerian women, breast cancer is diagnosed at later stages, is more frequently triple-negative disease, and is far more frequently fatal than in Europe or the United States. We evaluated the contribution of an inherited predisposition to breast cancer in this population. Patients and Methods: Cases were 1,136 women with invasive breast cancer (mean age at diagnosis, 47.5 ± 11.5 years) ascertained in Ibadan, Nigeria. Patients were selected regardless of age at diagnosis, family history, or prior genetic testing. Controls were 997 women without cancer (mean age at interview, 47.0 ± 12.4 years) from the same communities. BROCA panel sequencing was used to identify loss-of-function mutations in known and candidate breast cancer genes. Results: Of 577 patients with information on tumor stage, 86.1% (497) were diagnosed at stage III (241) or IV (256). Of 290 patients with information on tumor hormone receptor status and human epidermal growth factor receptor 2, 45.9% (133) had triple-negative breast cancer. Among all cases, 14.7% (167 of 1,136) carried a loss-of-function mutation in a breast cancer gene: 7.0% in BRCA1, 4.1% in BRCA2, 1.0% in PALB2, 0.4% in TP53, and 2.1% in any of 10 other genes. Odds ratios were 23.4 (95% CI, 7.4 to 73.9) for BRCA1 and 10.3 (95% CI, 3.7 to 28.5) for BRCA2. Risks were also significantly associated with PALB2 (11 cases, zero controls; P = .002) and TP53 (five cases, zero controls; P = .036). Compared with other patients, BRCA1 mutation carriers were younger ( P < .001) and more likely to have triple-negative breast cancer ( P = .028). Conclusion: Among Nigerian women, one in eight cases of invasive breast cancer is a result of inherited mutations in BRCA1, BRCA2, PALB2, or TP53, and breast cancer risks associated with these genes are extremely high. Given limited resources, prevention and early detection services should be especially focused on these highest-risk women.Keywords
This publication has 32 references indexed in Scilit:
- Mutations in context: implications of BRCA testing in diverse populationsFamilial Cancer, 2018
- Focusing attention on ancestral diversity within genomics research: a potential means for promoting equity in the provision of genomics based healthcare services in developing countriesJournal of Community Genetics, 2017
- A perfect storm: How tumor biology, genomics, and health care delivery patterns collide to create a racial survival disparity in breast cancer and proposed interventions for changeCA: A Cancer Journal for Clinicians, 2015
- Refined histopathological predictors of BRCA1 and BRCA2mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortiaBreast Cancer Research, 2014
- An Epidemiologic Investigation of Physical Activity and Breast Cancer Risk in AfricaCancer Epidemiology, Biomarkers & Prevention, 2014
- Recurrent BRCA1 and BRCA2 mutations in breast cancer patients of African ancestryBreast Cancer Research and Treatment, 2012
- High prevalence of BRCA1 and BRCA2 mutations in unselected Nigerian breast cancer patientsInternational Journal of Cancer, 2011
- Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencingProceedings of the National Academy of Sciences, 2011
- New therapies for metastatic disease addressed in updated NCCN Guidelines for breast cancer.2011
- Searching for large genomic rearrangements of the BRCA1 gene in a Nigerian populationBreast Cancer Research and Treatment, 2010